Presence of fragmented QRS is associated with increased epicardial adipose tissue thickness in hypertensive patients
MetadataShow full item record
CitationBekar, L., Kalçık, M., Çelik, O., Alp, Ç., Yetim, M., Doğan, T., ... & Gölbaşı, Z. (2019). Presence of fragmented QRS is associated with increased epicardial adipose tissue thickness in hypertensive patients. Journal of Clinical Ultrasound, 47(6), 345-350.
Background: Epicardial adipose tissue (EAT) is a cardiometabolic risk factor, and its possible relationship with hypertension has been reported previously. Fragmented QRS (fQRS) detected on electrocardiography (ECG) has been demonstrated to be a marker of myocardial fibrosis. In this study, we aimed to investigate the relationship between the thickness of EAT, and presence of fQRS in hypertensive patients. Methods: Consecutive patients who were diagnosed with hypertension were included in the study. ECG and transthoracic echocardiography (TTE) were performed to all patients. fQRS was defined as additional R ' wave or notching/splitting of S wave in two contiguous ECG leads. Thickness of EAT was measured by TTE. Results: This study enrolled 69 hypertensive patients with fQRS on ECG and 45 hypertensive patients without fQRS as the control group. Age (P =.869), and gender distribution (P =.751) were similar in both groups. Left atrial diameter (P =.012), interventricular septal thickness (P <.001), posterior wall thickness (P <.001), left ventricular ejection fraction (P =.009), left ventricular mass (P =.006), left ventricular mass ındex (P =.014), left ventricular hypertrophy (P =.003), and EAT thickness (P <.001) were found to be significantly increased in patients with fQRS. In multivariate analysis, among these variables only EAT was observed to be an independent predictor of fQRS (odds ratio:3.306 [95% confidence interval, 0.030-0.118], P =.001). Conclusion: A significant association exists between the presence of fQRS and EAT thickness in hypertensive patients. The presence of fQRS, just as EAT thickness, may be used as a cardiometabolic risk factor in hypertensive patients. © 2019 Wiley Periodicals, Inc.